•  
  •  
 

Submission Guidelines

Contents

General Submission Rules

Anyone may submit an original article to be considered for publication in Advances in Clinical Medical Research and Healthcare Delivery (ACMRHD) provided he or she owns the copyright to the work or is authorized by the copyright owner to submit the article. Authors are the initial owners of the copyrights to their works (an exception in the non-academic world to this might exist if the authors have, as a condition of employment, agreed to transfer copyright to their employer).

Submitted articles cannot have been previously published, nor be forthcoming in an archival journal or book. Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to ACMRHD, the author is stipulating that the material is not currently under review at another journal and that he or she will not submit the material to another journal until the completion of the editorial decision process ACMRHD. For those manuscripts that are based on material that may have been presented in abstract or poster form previously, please ensure that you are the copyright holder and can utilize the same material. If you are not the copyright holder, you will need the permission of the copyright holder to re-use text from the abstract or poster.

{ top }

Rights for Authors and ACMRHD

As further described in our Submission Agreement, in consideration for publication of the article, the authors assign to ACMRHD all copyright in the article, subject to the expansive personal--use exceptions described below.

Attribution and Usage Policies

Reproduction, posting, transmission or other distribution or use of the article or any material therein, in any medium as permitted by a personal-use exemption or by written agreement of ACMRHD, requires credit to ACMRHD as copyright holder (e.g.,Advances in Clinical Medical Research and Healthcare Delivery © 2021).

Personal-use Exceptions

The following uses are always permitted to the author(s) and do not require further permission from ACMRHD provided the author does not alter the format or content of the articles, including the copyright notification:

  • Storage and back-up of the article on the author's computer(s) and digital media (e.g.,thumb drives, etc.), provided that the article stored is not readily accessible by persons other than the author(s);
  • Posting of the article on the author(s) personal website, provided that the website is non-commercial;
  • Posting of the article on the internet as part of a non-commercial open access institutional repository or other non-commercial open access publication site affiliated with the author(s)'s place of employment (e.g., a Phrenology professor at the University of Southern North Dakota can have her article appear in the University of Southern North Dakota's Department of Phrenology online publication series); and
  • Posting of the article on a non-commercial course website for a course being taught by the author at the university or college employing the author.

{ top }

Conflict of Interest

According the guidelines of the Association of American Medical Colleges, The Council of Science Editors and the World Association of Medical Editors, Conflict of Interest (COI) in scientific publications refers to "situations in which financial or other personal considerations may compromise or have the appearance of compromising, an investigator's professional judgment in conducting or reporting research."

When a researcher, author, editor, or reviewer has a financial/non-financial interest or belief that could affect his/her objectivity, or inappropriately influence his/her actions, a potential conflict of interest exists. Such relationships are also known as dual commitments, competing interests, or competing loyalties.

ACMRHD requires authors to state all conflicting interests in relation to their work. The manuscript must include a 'conflict of interest' section at the end of the manuscript listing all the financial and non-financial issues. Where authors have no conflicting interests, they should mention clearly with a statement such as, "I, < >, on behalf of all the co-authors declare that author(s) have no conflict of interest with this manuscript". The Editor-In-Chief may ask for further information regarding conflicting interests. During the Peer-Review process, if any editor or reviewer identify conflicting interests with the review, he/she inform to the Journal Management Team immediately and their name will be excluded from the review team for that article.

Conflict of Interest relating to Financial Issues :

The conflicting interests related to financial issues include, but not limited to, following aspects:

Receiving reimbursements, fees, funding, or other monetary benefits from any organization or person that may in any way gain or lose financially from the publication of the manuscript, either now or in the future.

Receiving reimbursements, fees, funding, or other monetary benefits from any organization or person that holds or has applied for patents relating to the content of the manuscript.

Conflict of Interest relating to Non-Financial Issues:

The conflicting interests related to non-financial issues could include, but are not limited to, the following: Conflicts related to religion, to academic and intellectual interests or to personal opinion or ideologies.

Please note: Authors should ensure that publications are produced in a responsible and ethical manner. The authors working on any sponsored clinical trials or publications, should declare such works under conflict of Interest during submission.

The COI policies are formulated to ensure transparency and objectivity in the publications and Peer-Review process. If scholars are uncertain whether their concerns come under COI policies, please feel free to contact us at Advances@Rochesterregioinal.org.

{ top }

Human and Animal Rights

ACMRHD has formulated policies to ensure protection and proper use of animals and humans in all forms of research. It is mandatory for the authors reporting experiments with the involvement of animals and human subjects to adhere to following facets:

The authors should include a statement in the "Methods" section of the article that they have identified the related institutional and/or licensing committee and have taken approval from the committee for their experiments. They should also mention the address of the committee.

The authors should declare that they have conducted all experiments in accordance with relevant guidelines and regulations of the committee.

If an author performs experimental studies involving client-owned animals, he/she must present an acceptance document from the client about best practices in animal testing. Field studies and other non-experimental research on animals must observe institutional, national, or international guidelines, and wherever available should have been approved by an appropriate ethics committee.

The authors involved in research and experiments involving human subjects must confirm that informed consent was obtained from all participants and/or their legal guardians.

The U.S. Public Health Service's Policy on Humane Care and Use of Laboratory Animals (PHS policy) and the Guide for the Care and Use of Laboratory Animals describe general policies and procedures designed to ensure the humane and appropriate use of live vertebrate animals in all forms of medical research. ACMRHD finds the policies and procedures set forth in the PHS policy and the Guide for the Care and Use of Laboratory Animals to be both necessary and sufficient to ensure a high standard of animal care. The researchers are expected to conduct their animal research in compliance with PHS policy.

The Editor-In-Chief will evaluate the submitted manuscripts on animal well-being issues and if the research is found to be inconsistent with commonly accepted norms of using the animal and human subjects, the manuscript is liable to be rejected. The Editor-In-Chief also reserve the right to contact the approving committee for any further clarification.

Researchers note that they have a moral obligation towards the animals and human subjects they use for their research goals and they must treat them with compassion and consider their well-being while designing the projects.

{ top }

Informed Consent

Informed consent is required for any research paper to be published in ACMRHD if that research involves human participants. Informed Consent policy states that a participant in research must be informed about all aspects of the trial and the research should be carried out only when the participant voluntarily confirms his or her willingness to participate in a particular clinical trial and significance of the research for advancement of medical knowledge and social welfare. The concept of informed consent is embedded in the principles of Nuremberg Code, The Declaration of Helsinki and The Belmont Report.

Informed consent is an inevitable requirement prior to every research involving human beings as subjects for study. Policies regarding Informed Consent involves following postulates:

Human participants' names and other identifiers must be removed from all sections of the manuscript, including supplementary information. Informed consent letter must be attained for the publication of any other information that could lead to identification of a participant, such as clinical images and videos. In the methods section, the authors should include that informed consent to publish identifying information/images has been obtained. Please note that the use of colored bars/shapes to obscure the eyes/facial region of study participants is NOT an acceptable means of anonymization.

Scientific Reports will not process manuscripts describing research that involves organs/tissues procured from prisoners. In addition to the requirements described above, authors of manuscripts describing human transplantation research must include a statement in their manuscript confirming that no organs/tissues were procured from prisoners. Authors should respect the privacy of organ donors and also provide details of the institutions through which all organs/tissues were obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript. Further information and documentation to support this should be made available to the Editor-In-Chief on request. Manuscripts may be rejected if the Editor-In-Chief considers that the research has not been carried out within an appropriate ethical framework.

Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient's clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors' institution. In case of a novel procedure, authors are expected to obtain ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool.

For all research involving human subjects, informed consent to participate in the study should be obtained from participants or their parent/ legal guardian in case the participant is minor and a statement to this effect should appear in the manuscript.

For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants or their parent or legal guardian in case the participant is minor and a statement to this effect should appear in the manuscript.

All contributors who do not meet the criteria for authorship should be listed in an 'Acknowledgements' section. This section might include a person who provided purely technical help or writing assistance, or any sort of general support in performing research.

ACMRHD strictly follows COPE guidelines and requires written confirmation from all authors that they agree with any proposed changes in authorship of submitted manuscripts or published articles. The corresponding author should ensure that all authors confirm and agree with the proposed changes. The Editor-In-Chief will not be responsible to resolve authorship disputes. The authorship of a published article can only be amended through publication of a request letter.

{ top }

Article Types and Word Counts

Structured Abstracts must be divided into Background, Methods, Results, and Discussion sections with a maximum of 350 words.

Unstructured Abstracts must be no more than 250 words.

Type

Word Limit

Table/Figure Limit

Abstract

Article

2500

10

Structured

Case Report

1500

5

Unstructured

Clinical Trial

3500

10

Structured

Editorial

1500

5

Unstructured

Electronic Supplementary Material

N/A

N/A

Unstructured

Guideline

60,000

20

Structured

Historical Article

2000

5

Unstructured

Imaging-Video-Audio Media

N/A

N/A

Unstructured

Letter

1500

5

N/A

Meta-Analysis/Systematic Review

5000

20

Structured

Observational Study

2500

10

Structured

Personal Narrative

1500

5

Unstructured

Review

2500

10

Structured

Support of Research

N/A

N/A

Unstructured

{ top }

Formatting your paper

ACMRHD uses the American Medical Association Manual of Style, 11th edition, for formatting papers.

  • Do not include a title page, abstract, keywords or page numbers.
  • Submit your manuscript, including tables, figures, appendices, etc., as one file. Manuscript file must be a Word document.
  • Also submit a separate file for each table, figure, image or appendix - one file per item.
  • Page size: 8.5 x 11-inches.
  • All margins (left, right, top and bottom) should be 1.5 inches.
  • Line spacing: single space except before and after a section heading.
  • Font: body—12 pt. Times New Roman; footnotes—10 pt. Times .
  • Indentation: first line of the first paragraph under a heading is not indented. Subsequent paragraphs are indented.
  • Don't "widow" or "orphan" text (i.e., ending a page with the first line of a paragraph or beginning a page with the last line of a paragraph).
  • Justification: text should be single column, left-and-right justified, distributed evenly between both margins.
  • Language: submissions must be in English.
  • Use proper English grammar. The Elements of Style by William Strunk, Jr. and E. B. White is the "standard" guide, but other excellent guides (e.g., The Chicago Manual of Style, University of Chicago Press) exist as well.
  • Markup: please make sure to turn off comments and mark up in the final submitted version.
  • Emphasized text: whenever possible use italics to indicate text you wish to emphasize rather than underlining it or using color.
  • Headings: Times New Roman, 12 point, Bold, capitalize major words in headings.
  • Tables and Figures: appear in the document near where they are referenced. Each table and figure should be identified according to the order they appear in the document. (i.e. Table 1.). Figure number and title appear at the top of the figure. Figure notes appear at bottom of the figure. Figure title and notes should be enclosed by a border. The title of the table is in the first row of the table, notes are in the last row, both left justified. Tables should not contain vertical lines or outside borders.
  • Mathematics: Roman letters used in mathematical expressions as variables should be italicized. Roman letters used as part of multi-letter function names should not be italicized. Whenever possible, subscripts and superscripts should be a smaller font size than the main text.
  • Mathematical expressions should be typed inline. Longer expressions should appear as display math.
  • Conflict of Interest/Funding Statements; authors should provide a list of all potential conflicts of interest relevant to the manuscript. List conflicts of interest, or a statement that none exist, at the end of the document before the reference list.
  • The reference list should appear at the end of the document as a new page. Use the word References as a heading, left justified. The reference list should be single spaced and follow the AMA guidelines.

{ top }

Formatting References

ACMRHD uses the American Medical Association style for formatting references. See examples below.

AMA format for in-text references

Use superscript Arabic numbers within the text to cite information (e.g.,1, 2, 3…) with each number referring to the numbered citation on the reference list at the end of the document.

AMA format for reference list

Your reference list should appear on a separate page at the end of the article. The references should be listed in the order they were cited in the paper.

AMA format for journal articles:

Author Last Name First Initial Middle Initial. Title of article. Accepted Abbreviation of Journal Title. Year; Volume:Inclusive Page Numbers. doi.(if available)

In listed references, the names of all authors should be given unless there are more than 6, in which case the names of the first 3 authors are used, followed by “et al.".

You can find the accepted abbreviation of a journal at the National Library of Medicine Catalog.

Example of AMA format for journal articles:

Muller R. Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatol Int. 2021; 24:1-4. doi: 10.1007/s00296-021-04868-6.

AMA format for books:

Editor’s Last Name First Initial Middle Initial followed by “eds". Title of Book. Edition number. Name of Publisher; Year.

Example of AMA format for books:

Goldman L, Schafer AI, Cecil R, eds.Goldman-Cecil Medicine. Elsevier; 2020.

AMA format for book chapters:

Chapter Author Last Name First Initial Middle Initial. Title of chapter. In: Name of Book.Edition Number. Editors Last Name First Initial Middle Initial, eds. Name of Publisher; Year.

Example of AMA format for book chapters:

Yagyu S, Iehara T. MYCN nonamplified neuroblastoma: Detection of tumor-derived cell-free DNA in serum for predicting prognosis of neuroblastoma. In Hayat MA, ed. Pediatric Cancer Diagnosis, Therapy, and Prognosis. Springer; 2013:11-17.

AMA format for websites:

Authors (if indicated). Organization responsible for the site. Title of page or document. Available at: URL. Accessed Month, day, year.

Example of AMA format for websites:

Center for Disease Control. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html. Accessed May 27, 2021.

Checklist for formatting submissions.